Mass balance and metabolic profiling of [14C]AZD5672 in healthy male volunteers

Study identifier:D1710C00010

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open-Label, Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics following a Single Oral Dose of [14C]AZD5672 in Healthy Male Volunteers

Medical condition

Rheumatoid Arthritis

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD5672

Sex

Male

Actual Enrollment

4

Study type

Interventional

Age

50 Years +

Date

Study Start Date: 01 Jun 2008
Primary Completion Date: -
Study Completion Date: 01 Jul 2008

Study design

Allocation: N/A
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria